News

AmLactin Unveils Special Lotion with Champion Amber Glenn

AmLactin Unveils Special Lotion with Champion Amber Glenn

AmLactin Celebrates Unique Collaboration with Amber Glenn

AmLactin is thrilled to announce its year-long partnership with U.S. Figure Skating National Champion Amber Glenn. This exciting collaboration has led to the creation of a limited-edition moisturizer called AmberLactin Daily Confidence-Boosting Lotion. The lotion is designed to provide users with skin as smooth as ice, an attribute that resonates with the grace and precision of figure skating.

Introducing the AmberLactin Daily Confidence-Boosting Lotion

The AmberLactin Daily Confidence-Boosting Lotion incorporates a refined formula that features an upgraded concentration of Lactic Acid, a key ingredient known for its exfoliating properties. This new product remains true to AmLactin’s commitment to effective skincare, offering the transformative benefits that loyal users have come to depend on for soft and smooth skin.

Enhanced Formula for Optimal Skin Care

One of the highlights of the new AmberLactin lotion is its unique formulation, which boasts 5% Lactic Acid and essential Vitamins B3, D, and E, along with three types of Ceramides. This powerful combination facilitates effortless exfoliation and deeply hydrates the skin. The brand has also made strides in improving the lotion’s scent profile by discovering a new Lactic Acid salt that eliminates the original smell without compromising its fragrance-free quality.

Amber Glenn’s Experience with AmberLactin

Amber Glenn, renowned for her achievements in figure skating, expressed her enthusiasm for the new lotion. She explains, "This product has truly been a gamechanger for my sensitive skin. Balancing the demands of the rink and daily life can leave my skin feeling dry. However, with AmberLactin, my skin remains smooth and hydrated. Just as I strive for excellence on the rink, AmLactin supports my journey to achieve superior skincare."

Engaging the Community with a Social Media Giveaway

To celebrate the launch of the AmberLactin Daily Confidence-Boosting Lotion, the brand is hosting a giveaway. This contest invites all Amber Glenn fans and AmLactin enthusiasts to participate through social media platforms. Applicants need to engage with the giveaway post, which includes liking the post, tagging a friend, and following both AmLactin and Amber Glenn on their respective social media accounts.

Giving Back Through Partnership

The partnership began with the #IAmLactinReady campaign, a narrative where Amber shared her skincare journey, particularly in dealing with Keratosis Pilaris. Through this ongoing campaign, Amber highlighted how AmLactin plays a crucial role in maintaining her skin's softness during harsh winter months and the changing seasons.

Additionally, AmLactin is making a meaningful contribution by donating a portion of the proceeds to a charitable organization that supports the LGBTQ+ community, further cementing their commitment to social causes. This donation reflects the personal values that Amber Glenn holds dear and represents a partnership that transcends beauty, embracing a greater purpose.

Relationship with the Consumers

AmLactin emphasizes its dedication to formulating products that prioritize skin health. Over the years, they have become the #1 dermatologist-recommended moisturizer brand with lactic acid. The company's philosophy revolves around providing effective skincare solutions that cater to various skin concerns, ensuring that every product is developed with care and expertise.

Stay Connected with AmLactin

For those who are interested in learning more, AmLactin invites you to stay connected through various social media platforms for updates, skincare tips, and news about the AmberLactin Daily Confidence-Boosting Lotion. Engaging with this community can provide insights into achieving the best results in skincare.

Frequently Asked Questions

What is AmberLactin Daily Confidence-Boosting Lotion?

This lotion is a special moisturizer formulated in partnership with Amber Glenn, designed to provide smooth and hydrated skin through upgraded Lactic Acid properties.

What are the key ingredients in AmberLactin lotion?

The lotion contains 5% Lactic Acid, Vitamins B3, D, and E, along with three Ceramides to enhance skin texture and hydration.

How can I participate in the giveaway?

To enter the giveaway, like the giveaway post, tag a friend, and follow both AmLactin and Amber on their social media accounts.

What does the #IAmLactinReady campaign focus on?

The campaign shares Amber Glenn's skincare journey with Keratosis Pilaris and how AmLactin products help maintain her skin's health.

How does AmLactin contribute to social causes?

AmLactin is donating a portion of proceeds to a nonprofit organization supporting LGBTQ+ youth, reflecting their commitment to social responsibility.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 144

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 44

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 44

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 46

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 28

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 114

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

MindMaze Therapeutics: 2026 Business Update and Insights

Updated Category News Views 16

Breaking Down MindMaze’s 2026 Update Today, I’m sifting through MindMaze Therapeutics' latest half-year report like a prospector panning for gold nuggets. It’s a mixed bag, folks, full of expansion optimism underlined by a nagging loss in the financial ledger. But they say fortune favors the bold, right? The company has ambitious ideas, and their genetic makeup...

Continue Reading
Tantrum Sportfishing Celebrates Record Blue Marlin Achievement

Updated Category News Views 190

Historic Milestone for Tantrum Sportfishing In an inspiring turn of events for the sportfishing community, Tantrum Sportfishing has achieved a remarkable milestone. The Kona-based charter company announced its proud entry into the illustrious "Grander Club" after landing a colossal 1,039-pound Blue Marlin. This catch not only signifies a personal triumph for the team but...

Continue Reading
New Bitcoin ETF Offers Investors Unique Downside Protection

Updated Category News Views 227

Calamos Introduces a Groundbreaking Bitcoin ETF Investment management firm Calamos is excited to roll out an innovative approach to cryptocurrency investing with the launch of the world’s first 100% downside-protected Bitcoin exchange-traded fund (ETF). This launch comes just after an announcement suggesting that an ETF will be available for investors looking to...

Continue Reading
Exciting Developments in dsm-firmenich's Share Repurchase Initiative

Updated Category News Views 178

Progress Update on dsm-firmenich's Share Repurchase Program dsm-firmenich, known for its innovative approach in the fields of nutrition, health, and beauty, is actively implementing its large-scale share repurchase program. This initiative began earlier this year and signifies a strategic move to enhance shareholder value and manage capital effectively. Initial...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 133

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading